These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1683693)

  • 1. Dopamine agonists, a new perspective in cardiovascular therapy?
    Girbes AR; van Veldhuisen DJ; Smit AJ
    Neth J Med; 1991 Aug; 39(1-2):65-71. PubMed ID: 1683693
    [No Abstract]   [Full Text] [Related]  

  • 2. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and dopamine receptor agonists in cardiovascular therapy.
    Murphy MB; Elliott WJ
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
    Casagrande C; Merlo L; La Regina A
    J Auton Pharmacol; 1990; 10 Suppl 1():s85-93. PubMed ID: 1983011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
    Hasenfuss G; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():191-6. PubMed ID: 2573341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
    Andrés A; García-Robles R; Alcázar JM; Alvarez C; Martínez J; Oliet A; Sancho J; Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1989 Dec; 7(6):S326-7. PubMed ID: 2576671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.
    MacDonald TM; Jeffrey RF; Muir AL; Lee MR
    Eur J Clin Pharmacol; 1990; 38(2):199-201. PubMed ID: 1970961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction study of fenoldopam--digoxin in congestive heart failure.
    Strocchi E; Tartagni F; Malini PL; Valtancoli G; Ambrosioni E; Pasinelli F; Riva E; Fuccella LM
    Eur J Clin Pharmacol; 1989; 37(4):395-7. PubMed ID: 2574674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
    Carey RA; Jacob L
    J Clin Pharmacol; 1989 Mar; 29(3):207-11. PubMed ID: 2566626
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose study of the effects of fenoldopam and enalapril in mild hypertension.
    MacDonald TM; Jeffrey RF; Freestone S; Lee MR
    Eur J Clin Pharmacol; 1991; 40(3):231-6. PubMed ID: 1676367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Nov; 134(47):2281-4. PubMed ID: 1979426
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. SK&F Fenoldopam Working Group.
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):445-6. PubMed ID: 1355665
    [No Abstract]   [Full Text] [Related]  

  • 19. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
    Aronson S; Goldberg LI; Roth S; Glock D; Moss J; Roizen MF
    Can J Anaesth; 1990 Apr; 37(3):380-4. PubMed ID: 1969772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.